Brand profile · Biotechnology Research

Avecris

Avecris is a Biotechnology Research brand in Singapore. Ownership is privately held; it publishes at avecris.com. It holds one address on record, all in Singapore. The record counts 6 people. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Grant, US$5.0K. It is listed alongside seven similar brands, mostly in Biotechnology Research.

Profile live Privately Held Founded 2022 1 entity UEN 1 office country US$ 5.0K Grant
Registry verified · ACRA

Key facts

Counted staff
6
self-reported 2–10 band
Founded
2022
4 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
2
Grant · Sep 2022 · US$ 5.0K
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

Avecris: 1 registry entityAvecris is linked to 1 registry entity: AVECRIS PTE. LTD. (UEN 201735118Z, confirmed).AvecrisAVECRIS PTE. LTD.UEN 201735118ZConfirmed · ACRA
Show as table · Avecris: 1 registry entity
Avecris: 1 registry entity
AVECRIS PTE. LTD.UEN 201735118Z
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

At Avecris, we are developing an innovative genetic vector platform technology that will enable a new class of medicines. Our technology is:

Universally programmable Scalable Redosable Non-integrating Cell-type specific Low cost

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary SG. Codes: SG.1 countryprimary SGSG
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countrySG

All codes: SG

Addresses

  • SGSingaporePrimary

Grid intelligence Members

Funding

Last round · 10 September 2022US$ 5.0KGrant · investor: First Flight Venture Center
Rounds2
Round typeGrant · non-equity funding
Amount (USD)5,000
Stage rank1
Investors named1
Since last round3 yr 4 mo

Funding

2 funding roundsFunding timeline. Latest round 10 Sep 2022: Grant, US$ 5.0K.20222026GrantUS$ 5.0K2 rounds
Show as table · 2 funding rounds
2 funding rounds
Rounds2
Axis2022 to 2026
Grant · 10 Sep 2022US$ 5.0K

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

3 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Avecris?

One Singapore entity on ACRA. AVECRIS PTE. LTD. (UEN 201735118Z), high confidence.

How many people work at Avecris?

The record holds 6 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does Avecris have offices?

One address on record, Singapore only. Primary: Singapore.

Has Avecris raised funding?

Two rounds. Latest 10 September 2022: grant, US$5,000, investor First Flight Venture Center.

Which companies are listed alongside Avecris?

4 profiles list Avecris as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. Ananda Immunotherapies and DotBio list it back.

What is Avecris's website?